Virology

A $707 million investment in cell-based influenza vaccine

The United States has provided a large sum of money to pharmaceutical giant Novartis to produce influenza vaccines grown in cell culture. According to CIDRAP: Novartis's US efforts have been spurred by two major federal contracts. In 2006 the firm won a $220 million HHS contract to develop cell-based flu ...

Megavirus, the biggest known virus

The mantle of world's biggest virus has passed from Mimivirus to Megavirus. But in this case, size doesn't matter. It's the genes that these viruses share and do not share that make this story important. The discovery of Mimivirus in a French cooling tower amazed virologists. At 750 nanometers in ...

TWiV 161: Concerto in B

Hosts: Vincent Racaniello, Rich Condit, Alan Dove, and Gabriel Victora Vincent, Rich, Alan and Gabriel review the production of antibodies by B cells, and how high affinity antibodies are selected in the germinal centers of lymph nodes. Please help us by taking our listener survey. [powerpress url="http://traffic.libsyn.com/twiv/TWiV161.mp3"] Click the arrow above to ...

Ferreting out influenza H5N1

A laboratory in the Netherlands has identified a lethal influenza H5N1 virus strain that is transmitted among ferrets. These findings are under review by the National Science Advisory Board for Biosecurity (NSABB) to ensure that they do not constitute a threat to human health. Meanwhile both the popular and scientific ...

TWiV 160: Moore tumor viruses

Hosts: Vincent Racaniello, Rich Condit, Alan Dove, Dickson Despommier, and Patrick Moore The TWiV team speaks with Patrick Moore about his discovery, with Yuan Chang, of two human tumor viruses, Kaposi's sarcoma herpesvirus and Merkel cell polyomavirus. Please help us by taking our listener survey. [powerpress url="http://traffic.libsyn.com/twiv/TWiV160.mp3"] Click the arrow above to ...
Scroll to Top